TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,113
|
1,851
|
1,487 |
| Financial expenses |
16
|
20
|
16 |
| Earnings before taxes |
-2,086
|
-1,804
|
-3,399 |
| EBITDA |
-2,004
|
-1,724
|
-3,327 |
| Total assets |
1,337
|
1,224
|
1,797 |
| Current assets |
1,255
|
1,077
|
1,617 |
| Current liabilities |
364
|
441
|
810 |
| Equity capital |
198
|
283
|
587 |
| - share capital |
63
|
63
|
63 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
14.8%
|
23.1%
|
32.7% |
| Turnover per employee |
528
|
463
|
372 |
| Profit as a percentage of turnover |
-98.7%
|
-97.5%
|
-228.6% |
| Return on assets (ROA) |
-154.8%
|
-145.8%
|
-188.3% |
| Current ratio |
344.8%
|
244.2%
|
199.6% |
| Return on equity (ROE) |
-1053.5%
|
-637.5%
|
-579.0% |
| Change turnover |
262
|
364
|
325 |
| Change turnover % |
14%
|
24%
|
28% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.